Ten years of gene targeting: Targeted mouse mutants, from vector design to phenotype analysis

Mechanisms of Development

Volumn 82, Issue 1-2, 1999, Pages 3-21

  Müller, Ulrike ^a  

^a MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

Author keywords

Gene targeting; Genetic background; Homologous recombination; Inducible gene expression; Knockout; Modifier loci

Indexed keywords

GENE TARGETING; GENETIC ANALYSIS; GENETIC RECOMBINATION; KNOCKOUT MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BASE SEQUENCE; DNA, RECOMBINANT; FEMALE; GENE TARGETING; GENETIC COMPLEMENTATION TEST; GENETIC ENGINEERING; GENETIC VECTORS; HISTORY, 20TH CENTURY; INTEGRASES; MALE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHENOTYPE; VIRAL PROTEINS;

EID: 0342449328     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(99)00021-0     Document Type: Review

References (150)

1. Albert H., Dale E.C., Lee E., Ow D.W. Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant Journal. 7:1995;649-659.
2. Akagi K., Sandig V., Voojis M., Van der Valk M., Giovannini M., Strauss M., Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res. 25:1997;1766-1773.
3. Araki K., Araki M., Miyazaki J., Vassalli P. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc. Natl. Acad. Sci. USA. 92:1995;160-164.
4. Araki K., Araki M., Yamamura K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 25:1997;868-872.
5. Askew G.R., Doetschman T., Lingrel J.B. Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13:1993;4115-4124.
6. Baribault H., Penner J., Iozzo R.V., Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:1994;2964-2973.
7. Barlow C., Schroeder M., Lekstrom-Himes J., Kylefjord H., Deng C.X., Wynshaw-Boris A., Spiegelman B.M., Xanthopoulos K.G. Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments. Nucleic Acids Res. 25:1997;2543-2545.
8. Bethke, B., Sauer, B., 1997. Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants. Nucleic Acids Research 25(14), 2828-2834.
9. Betz U.A., Vosshenrich C.A., Rajewsky K., Muller W. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Curr. Biol. 6:1996;1307-1316.
10. Bonyadi M., Rusholme S.A., Cousins F.M., Su H.C., Biron C.A., Farrall M., Akhurst R.J. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nature Genet. 15:1997;207-211.
11. Bradley A., Evans M., Kaufman M.H., Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature. 309:1984;255-256.
12. Brandon, E.P., Idzerda, R.L., McKnight, G.S., 1995. Targeting the mouse genome: a compendium of knockouts. Curr. Biol. 5, 625-634 (Part I), 758-765 (Part II), 873-881 (Part III).
13. Bronson S.K., Plaehn E.G., Kluckman K.D., Hagaman J.R., Maeda N., Smithies O. Single-copy transgenic mice with chosen-site integration. Proc. Natl. Acad. Sci. USA. 93:1996;9067-9072.
14. Brook F.A., Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA. 94:1997;5709-5712.
15. Buchholz F., Ringrose L., Angrand P.O., Rossi F., Stewart A.F. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 24:1996;4256-4262.
16. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
17. Crabtree G.R., Schreiber S.L. Three-part inventions: intracellular signaling and induced proximity. Trends Biochem. Sci. 21:1996;418-422.
18. Crawley J.N. Unusual behavioral phenotype of inbred mouse strains. Trends Neurosci. 19:1996;181-182.
19. Dahme M., Bartsch U., Martini R., Anliker B., Schachner M., Mantei N. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nature Genet. 17:1997;346-349.
20. Deng C., Capecchi M.R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12:1992;3365-3371.
21. Detloff P.J., Lewis J., John S.W., Shehee W.R., Langenbach R., Maeda N., Smithies O. Deletion and replacement of the mouse adult beta-globin genes by a 'plug and socket' repeated targeting strategy. Mol. Cell. Biol. 14:1994;6936-6943.
22. de Wit T., Drabek D., Grosveld F. Microinjection of Cre recombinase RNA induces site-specific recombination of a transgene inmouse oocytes. Nucleic Acids Res. 26:1998;676-678.
23. Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton D.W., Thompson S., Smithies O. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature. 330:1987;57657-57658.
24. Donehower L.A., Harvey M., Vogel H., McArthur M.J., Montgomery C.A. Jr., Park S.H., Thompson T., Ford R.J., Bradley A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinogen. 14:1995;16-22.
25. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
26. Dorin J.R., Stevenson B.J., Fleming S., Alton E.W., Dickinson P., Porteous D.J. Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm. Genome. 5:1994;465-472.
27. Dymecki S.M. FLP recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6191-6196.
28. Erickson R.P. Mouse models of human genetic disease: which mouse is more like a man? Bioessays. 18:1996;993-998.
29. Evans M.J., Carlton M.B., Russ A.P. Gene trapping and functional genomics. Trends Genet. 13:1997;370-374.
30. Evans M.J., Kaufmann M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature. 292:1981;154-156.
31. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA. 93:1996;10887-10890.
32. Festing M. Inbred strains of mice. Mouse Genome. 94:1996;523-677.
33. Fiering S., Epner E., Robinson K., Zhuang Y., Telling A., Hu M., Martin D.I., Enver T., Ley T.J., Groudine M. Targeted deletion of 5′HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 9:1995;2203-2213.
34. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1996;1255-1264.
35. Friedrich G., Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5:1991;1513-1523.
36. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-181.
37. Gingrich J.R., Roder J. Inducible gene expression in the nervous system of transgenic mice. Annu. Rev. Neurosci. 21:1998;377-405.
38. Golic K.G. Site-specific recombination between homologous chromosomes in Drosophila. Science. 252:1991;958-961.
39. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90:1997;729-738.
40. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
41. Hanks M., Wurst W., Anson-Cartwright L., Auerbach A.B., Joyner A.L. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 269:1995;679-682.
42. Hasty P., Ramirez-Solis R., Krumlauf R., Bradley A. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature. 350:1991;243-246.
43. Hasty P., Rivera-Perez J., Bradley A. The length of homology required for gene targeting in embryonic stem cells. Mol. Cell. Biol. 11:1991;5586-5591.
44. Hennet T., Hagen F.K., Tabak L.A., Marth J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA. 92:1995;12070-12074.
45. Hogan, B., Beddington, R., Constantini, F., Lacy, E., 1994. Manipulating the Mouse Embryo, A laboratory manual. Cold Spring Harbour Laboratory Press, USA.
46. Hummler E., Cole T.J., Blendy J.A., Ganss R., Aguzzi A., Schmid W., Beermann F., Schutz G. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc. Natl. Acad. Sci. USA. 91:1994;5647-5651.
47. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., Prusiner S.B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 250:1990;1587-1590.
48. Jasin M., Moynahan M.E., Richardson C. Targeted transgenesis. Proc. Natl. Acad. Sci. USA. 93:1996;8804-8808.
49. Jones A., Korpi E.R., McKernan R.M., Pelz R., Nusser Z., Makela R., Mellor J.R., Pollard S., Bahn S., Stephenson F.A., Randall A.D., Sieghart W., Somogyi P., Smith A.J., Wisden W. Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J. Neurosci. 17:1997;1350-1362.
50. Joyner, A.L. (Ed.), 1993. Gene Targeting: a Practical Approach, 1st edn. Oxford University Press, New York.
51. Joyner, A.L. (Ed.), 1998. Gene Targeting: a Practical Approach. Oxford University Press, New York. Second edition, in press.
52. Kawase E., Suemori H., Takahashi N., Okazaki K., Hashimoto K., Nakatsuji N. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38:1994;385-390.
53. Kellendonk C., Tronche F., Monaghan A.P., Angrand P.O., Stewart F., Schutz G. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 24:1996;1404-1411.
54. Kilby N.J., Snaith M.R., Murray J.A. Site-specific recombinases: tools for genome engineering. Trends Genet. 9:1993;413-421.
55. Kobayashi K., Ohye T., Pastan I., Nagatsu T. A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell targeting. Nucleic Acids Res. 24:1996;3653-3655.
56. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
57. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA. 93:1996;5860-5865.
58. Lakso M., Sauer B., Mosinger B., Lee E.J., Manning R.W., Yu S.H., Mulder K.L., Westophal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;6232-6236.
59. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
60. Lathe R. Mice, gene targeting and behaviour: more than just genetic background. Trends Neurosci. 19:1996;183-186.
61. Ledermann B., Burki K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell Res. 197:1991;254-258.
62. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915-926.
63. Li Z.W., Stark G., Gotz J., Rulicke T., Gschwind M., Huber G., Muller U., Weissmann C. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 93:1996;6158-6162.
64. Liberles S.D., Diver S.T., Austin D.J., Schreiber S.L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl. Acad. Sci. USA. 94:1997;7825-7830.
65. Magara, F., Müller, U., Lipp, H.P., Weissmann, C., Stagliar, M., Wolfer, D.P., 1999. Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the β-amyloid-precursor protein. Proc. Natl. Acad. Sci. USA, in press.
66. Mansour S.L., Goddard J.M., Capecchi M.R. Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development. 117:1993;13-28.
67. Mansour S.L., Thomas K.R., Capecchi M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:1988;348-352.
68. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78:1981;7634-7638.
69. Matouk C., Gosselin D., Malo D., Skamene E., Radzioch D. PCR-analyzed microsatellites for the inbred mouse strain 129/Sv, the strain most commonly used in gene knockout technology. Mamm. Genome. 7:1996;603-605.
70. Matzuk M.M., Finegold M.J., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319.
71. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683.
72. McWhir J., Schnieke A.E., Ansell R., Wallace H., Colman A., Scott A.R., Kind A.J. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nature Genet. 14:1996;223-226.
73. Medberry S.L., Dale E., Qin M., Ow D.W. Intra-chromosomal rearrangements generated by Cre-lox site-specific recombination. Nucleic Acids Res. 23:1995;485-490.
74. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and FLP-mediated recombination. Nature Genet. 18:1998;136-141.
75. Moens C.B., Auerbach A.B., Conlon R.A., Joyner A.L., Rossant J. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 6:1992;691-704.
76. Moore R.C., Redhead N.J., Selfridge J., Hope J., Manson J.C., Melton D.W. Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Biotechnology. 13:1995;999-1004.
77. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16:1996;1337-1345.
78. Müller U., Cristina N., Li Z.W., Wolfer D.P., Lipp H.P., Rulicke T., Brandner S., Aguzzi A., Weissmann C. Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell. 79:1994;755-765.
79. Müller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
80. No D., Yao T.P., Evans R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;3346-3351.
81. O'Gorman S., Dagenais N.A., Qian M., Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 94:1997;14602-14607.
82. Ohno H., Goto S., Taki S., Shirasawa T., Nakano H., Miyatake S., Aoe T., Ishida Y., Maeda H., Shirai T. Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBO J. 13:1994;1157-1165.
83. Olson E.N., Arnold H.H., Rigby P.W., Wold B.J. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 85:1996;1-4.
84. Pease S., Williams R.L. Formation of germ-line chimeras from embryonic stem cells maintained with recombinant leukemia inhibitory factor. Exp. Cell Res. 190:1990;209-211.
85. Pham C.T., MacIvor D.M., Hug B.A., Heusel J.W., Ley T.J. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl. Acad. Sci. USA. 93:1996;13090-13095.
86. Picard D. Regulation of protein function through expression of chimaeric proteins. Curr. Opin. Biotech. 5:1994;511-515.
87. Raeber A.J., Race R.E., Brandner S., Priola S.A., Sailer A., Bessen R.A., Mucke L., Manson J., Aguzzi A., Oldstone M.B., Weissmann C., Chesebro B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16:1997;6057-6065.
88. Ramirez-Solis R., Liu P., Bradley A. Chromosome engineering in mice. Nature. 378:1995;720-724.
89. Ramirez-Solis R., Zheng H., Whiting J., Krumlauf R., Bradley A. Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell. 73:1993;279-794.
90. Ramirez-Solis R., Rivera-Perez J., Wallace J.D., Wims M., Zheng H., Bradley A. Genomic DNA microextraction: a method to screen numerous samples. Anal. Biochem. 201:1992;331-335.
91. Rickert R.C., Roes J., Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1997;1317-1378.
92. Rijli F.M., Dolle P., Fraulob V., LeMeur M., Chambon P. Insertion of a targeting construct in a Hoxd-10 allele can influence the control of Hoxd-9 expression. Dev. Dynam. 201:1994;366-377.
93. Rivera V.M., Clackson T., Natesan S., Pollock R., Amara J.F., Keenan T., Magari S.R., Phillips T., Courage N.L., Cerasoli F. Jr., Holt D.A., Gilman M. A humanized system for pharmacologic control of gene expression. Nature Med. 2:1996;1028-1032.
94. Rohlmann A., Gotthardt M., Willnow T.E., Hammer R.E., Herz J. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nature Biotech. 14:1996;1562-1565.
95. Rozmahel R., Wilschanski M., Matin A., Plyte S., Oliver M., Auerbach W., Moore A., Forstner J., Durie P., Nadeau J., Bear C., Tsui L.C. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12:1996;280-287.
96. Rudnicki M.A., Braun T., Hinuma S., Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 71:1992;383-390.
97. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261.
98. Santerre R.F., Allen N.E., Hobbs J.N. Jr., Rao R.N., Schmidt R.J. Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene. 30:1984;147-156.
99. Sauer B., Henderson N. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2:1990;441-449.
100. Schauwecker P.E., Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. USA. 94:1997;4103-4108.
101. Schmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A., von Mering C., Hangartner C., Aguzzi A., Weissmann C. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 93:1998;203-214.
102. Schultze N., Burki Y., Lang Y., Certa U., Bluethmann H. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotech. 14:1996;499-503.
103. Schwartzberg P.L., Goff S.P., Robertson E.J. Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science. 246:1989;799-803.
104. Schwegler H., Lipp H.P. Hereditary covariations of neuronal circuitry and behavior: correlations between the proportions of hippocampal synaptic fields in the region inferior and two-way avoidance in mice and rats. Behav. Brain Res. 7:1983;1-38.
105. Schwenk F., Kühn R., Angrand P.O., Rajewsky K., Stewart A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26:1998;1427-1432.
106. Schwenk F., Sauer B., Kukoc N., Hoess R., Muller W., Kocks C., Kuhn R., Rajewsky K. Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains. J. Immunol. Methods. 207:1997;203-212.
107. Schwenk F., Baron U., Rajewsky K. A Cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:1995;5080-5081.
108. Sendtner M., Gotz R., Holtmann B., Escary J.L., Masu Y., Carroll P., Wolf E., Brem G., Brulet P., Thoenen H. Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr. Biol. 6:1996;686-694.
109. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., Kanamaru R., Kanegae Y., Saito I., Nakamura Y., Shiba K., Noda T. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science. 278:1997;120-123.
110. Shockett P.E., Schatz D.G. Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. USA. 93:1996;5173-5176.
111. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238.
112. Sikorski R., Peters R. Transgenics on the Internet. Nature Biotechnol. 15:1997;289.
113. Silva A.J. Mutant mice and neuroscience: recommendations concerning genetic background. Banbury conference on genetic background in mice. Neuron. 19:1997;755-759.
114. Simpson E.M., Linder C.C., Sargent E.E., Davisson M.T., Mobraaten L.E., Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16:1997;19-27.
115. Smith A.J., De Sousa M.A., Kwabi-Addo B., Heppell-Parton A., Impey H., Rabbitts P. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nature Genet. 9:1995;376-385.
116. Smithies O., Gregg R.G., Boggs S.S., Koralewski M.A., Kucherlapati R.S. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature. 317:1985;230-234.
117. St-Onge L., Furth P.A., Gruss P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24:1996;3875-3877.
118. Stacey A., Schnieke A., McWhir J., Cooper J., Colman A., Melton D.W. Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol. Cell. Biol. 14:1994;1009-1016.
119. Stanton B.R., Perkins A.S., Tessarollo L., Sassoon D.A., Parada L.F. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 6:1992;2235-2247.
120. Stein P.L., Vogel H., Soriano P. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8:1994;1999-2007.
121. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1997;1699-1702.
122. te Riele H., Maandag E.R., Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA. 89:1992;5128-5132.
123. Telling G.C., Haga T., Torchia M., Tremblay P., DeArmond S.J., Prusiner S.B. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10:1996;1736-1750.
124. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90.
125. Telling G.C., Scott M., Hsiao K.K., Foster D., Yang S.L., Torchia M., Sidle K.C., Collinge J., DeArmond S.J., Prusiner S.B. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. USA. 91:1994;9936-9940.
126. Terry R.W., Kwee L., Baldwin H.S., Labow M.A. Cre-mediated generation of a VCAM-1 null allele in transgenic mice. Trans. Res. 6:1997;349-356.
127. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:1987;503-512.
128. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
129. Torres, R.M., Kühn, R., 1997. Laboratory protocols for conditional gene targeting. Oxford University Press, Oxford.
130. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 87:1996;1317-1326.
131. Upchurch M., Wehner J.M. Differences between inbred strains of mice in Moriis water maze performance. Behav. Genet. 18:1988;55-68.
132. Valancius V., Smithies O. Testing an 'in-out' targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol. Cell. Biol. 11:1991;1402-1408.
133. van den Broek M.F., Muller U., Huang S., Aguet M., Zinkernagel R.M. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:1995;4792-4796.
134. Van Deursen J., Fornerod M., Van Rees B., Grosveld G. Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc. Natl. Acad. Sci. USA. 92:1995;7376-7380.
135. von Koch C.S., Zheng H., Chen H., Trumbauer M., van der Ploeg L.H., Price D.L., Sisodia S.S. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging. 18:1997;661-669.
136. von Melchner H., DeGregori J.V., Rayburn H., Reddy S., Friedel C., Ruley H.E. Selective disruption of genes expressed in totipotent embryonal stem cells. Genes Dev. 6:1992;919-927.
137. Wagner, K.U., Wall, R.J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., Li, M., Furth, P.A., Henninghausen, L., 1997. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Research 25(21), 4323-4330.
138. Wang Y., Schnegelsberg P.N., Dausman J., Jaenisch R. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature. 379:1996;823-825.
139. Wang Y., DeMayo F.J., Tsai S.Y., O'Malley B.W. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnol. 15:1997;239-243.
140. Wehner J.M., Silva A. Importance of strain differences in evaluation of learning and memory processes in null mutants. Ment. Retard. Dev. Disab. Res Rev. 2:1996;243-248.
141. Weissmann, C., Weber, H., Taniguchi, T., Muller, W., Meyer, F., 1979. Reversed genetics: a new approach to the elucidation of structure-function relationship. Ciba Foundation Symposium, 47-61.
142. Wilson R.W., Ballantyne C.M., Smith C.W., Montgomery C., Bradley A., O'Brien W.E., Beaudet A.L. Gene targeting yields a CD18-mutant mouse for study of inflammation. J. Immunol. 151:1993;1571-1578.
143. Wolfer D.P., Muller U., Stagliar M., Lipp H.P. Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: a study using mice with a modified beta-amyloid precursor protein gene. Brain Res. 771:1997;1-13.
144. Wu C.L., Melton D.W. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nature Genet. 3:1993;235-240.
145. Yagi T., Ikawa Y., Yoshida K., Shigetani Y., Takeda N., Mabuchi I., Yamamoto T., Aizawa S. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc. Natl. Acad. Sci. USA. 87:1990;9918-9992.
146. You Y., Bergstrom R., Klemm M., Lederman B., Nelson H., Ticknor C., Jaenisch R., Schimenti J. Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nature Genet. 15:1997;285-288.
147. Zhang Y., Riesterer C., Ayrall A.M., Sablitzky F., Littlewood T.D., Reth M. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 24:1996;543-548.
148. Zheng H., Jiang M., Trumbauer M.E., Sirinathsinghji D.J., Hopkins R., Smith D.W., Heavens R.P., Dawson G.R., Boyce S., Conner M.W. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 81:1995;525-531.
149. Zou Y.R., Muller W., Gu H., Rajewsky K. Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. Curr. Biol. 4:1994;1099-1203.
150. Zinyk D.L., Mercer E.H., Harris E., Anderson D.J., Joyner A.L. Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr. Biol. 8:1998;665-668.